FCANX | HBLIX | FCANX / HBLIX | |
Total Expense Ratio | 1.54 | 0.65 | 237% |
Annual Report Gross Expense Ratio | 1.54 | 0.65 | 237% |
Fund Existence | 18 years | 15 years | - |
Gain YTD | -1.075 | 0.158 | -681% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2000 | - |
Min. Initial Investment IRA | 500 | N/A | - |
Net Assets | 1.95B | 11.5B | 17% |
Annual Yield % from dividends | 2.04 | 3.60 | 56% |
Returns for 1 year | 4.50 | 4.66 | 97% |
Returns for 3 years | 2.74 | 3.93 | 70% |
Returns for 5 years | 13.70 | 16.48 | 83% |
Returns for 10 years | 17.45 | 32.35 | 54% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
WDNA | 12.25 | 0.57 | +4.87% |
WisdomTree BioRevolution ETF | |||
FCEF | 20.37 | -0.06 | -0.29% |
First Trust Income Opportunity ETF | |||
CVIE | 57.19 | -0.21 | -0.37% |
Calvert International Responsible ETF | |||
HYT | 9.14 | -0.05 | -0.54% |
Blackrock Corporate High Yield Fund | |||
HIX | 3.96 | -0.02 | -0.63% |
Western Asset High Income Fund II |